Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
Recap of Tuesday’s Biotech Catalysts – End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.
Analysts Hit These 3 REITs With Lower Price Targets
The uncertain effects of larger economic trends may be part of the reason for analysts at finance firms to be lowering their price targets for these real estate investment trusts (REITs). If you own property, you are concerned about inflation and interest rates, and REITs whose business models are also dependent on such factors.
Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study
Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment of Stargardt Disease (STGD1).
Honest Company Shares Soar Following Launch On Walmart
Honest Company Inc (NASDAQ:HNST), known as the go-to clean, conscious lifestyle brand, launched in 2012 by Jessica Alba, has expanded…
Winnebago Launches New Mobile App To Enhance Ownership Experience
Recreation Vehicles maker Winnebago Industries Inc (NYSE:WGO) has launched a new mobile application for its customers. The customizable app provides information for…
Sorrento Shares Gain Following FDA’s Nod for Initial-Stage Covid-19 Study
Sorrento Therapeutics (NASDAQ: SRNE) announced that the U.S. Food and Drug Administration (FDA) has cleared the Phase 1 study of its candidate, STI-1558, in patients with impaired renal and hepatic function.
RBC Capital Lowers Inovio Price Target As It Awaits This
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ:INO) to $4 from $5 with a Sector Perform rating.…
JMP Is Bullish On This Cancer Stock “Sees New Way to Treat Cancer”
JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ:AURA) with a Market Outperform rating and a $26 risk-adjusted price target. Aura…